Visualization of Ceramide-Associated Proteins in Ceramide-Rich Platforms Using a Cross-Linkable Ceramide Analog and Proximity Ligation Assays With Anti-ceramide Antibody.
VDAC1
acetylated tubulin
ceramide
cross-link
lipid raft
microtubules
mitochondria
proximity ligation assay
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
05
2019
accepted:
30
07
2019
entrez:
3
9
2019
pubmed:
3
9
2019
medline:
3
9
2019
Statut:
epublish
Résumé
Ceramide-rich platforms (CRPs) mediate association of proteins with the sphingolipid ceramide and may regulate protein interaction in membrane contact sites to the cytoskeleton, organelles, and infectious pathogens. However, visualization of ceramide association to proteins is one of the greatest challenges in understanding the cell biology of ceramide. Here we introduce a novel labeling technique for ceramide-associated proteins (CAPs) by combining photoactivated cross-linking of a bioorthogonal and bifunctional ceramide analog, pacFACer with proximity ligation assays (PLAs). pacFACer cross-linked to CAPs is covalently attached to a fluorophore using click chemistry. PLAs use antibodies to: (1) the candidate CAP and the fluorophore (PLA1); and (2) the CAP and ceramide (PLA2). PLA1 shows the subcellular localization of a particular CAP that is cross-linked to pacFACer, while PLA2 tests if the cross-linked CAP forms a complex with endogenous ceramide. Two proteins, tubulin and voltage-dependent anion channel 1 (VDAC1), were cross-linked to pacFACer and showed PLA signals for a complex with ceramide and pacFACer, which were predominantly colocalized with microtubules and mitochondria, respectively. Binding of tubulin and VDAC1 to ceramide was confirmed by coimmunoprecipitation assays using anti ceramide antibody. Cross-linking to pacFACer was confirmed using click chemistry-mediated attachment of biotin and streptavidin pull-down assays. Inhibition of ceramide synthases with fumonisin B1 (FB1) reduced the degree of pacFACer cross-linking and complex formation with ceramide, while it was enhanced by amyloid beta peptide (Aβ). Our results show that endogenous ceramide is critical for mediating cross-linking of CAPs to pacFACer and that a combination of cross-linking with PLAs (cross-link/PLA) is a novel tool to visualize CAPs and to understand the regulation of protein interaction with ceramide in CRPs.
Identifiants
pubmed: 31475148
doi: 10.3389/fcell.2019.00166
pmc: PMC6706757
doi:
Types de publication
Journal Article
Langues
eng
Pagination
166Subventions
Organisme : NIA NIH HHS
ID : R01 AG034389
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS095215
Pays : United States
Références
J Biol Chem. 1992 Mar 15;267(8):5048-51
pubmed: 1312082
J Mol Med (Berl). 2004 Jun;82(6):357-63
pubmed: 15069600
Biochim Biophys Acta. 2005 Dec 30;1746(3):284-94
pubmed: 16226325
J Lipid Res. 2007 Apr;48(4):968-75
pubmed: 17210985
J Bioenerg Biomembr. 2008 Jun;40(3):163-70
pubmed: 18654841
Biol Chem. 2008 Nov;389(11):1371-9
pubmed: 18783339
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18746-51
pubmed: 19033201
J Lipid Res. 2009 Oct;50(10):2103-10
pubmed: 19372594
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10009-13
pubmed: 1946418
Expert Rev Proteomics. 2010 Jun;7(3):401-9
pubmed: 20536310
Adv Exp Med Biol. 2010;688:60-71
pubmed: 20919646
PLoS One. 2011;6(6):e19783
pubmed: 21695182
J Biol Chem. 2012 Jun 15;287(25):21384-95
pubmed: 22532571
J Pharmacol Exp Ther. 2012 Sep;342(3):637-41
pubmed: 22700429
Mol Biol Cell. 2012 Aug;23(16):3156-66
pubmed: 22718902
Hum Mol Genet. 2012 Dec 1;21(23):5131-46
pubmed: 22926141
J Am Chem Soc. 2014 Mar 26;136(12):4544-50
pubmed: 24588349
Mol Biol Cell. 2014 Jun;25(11):1715-29
pubmed: 24694597
Neuroscience. 2014 Oct 10;278:354-66
pubmed: 25168729
Chem Commun (Camb). 2015 Feb 11;51(12):2249-52
pubmed: 25567764
Mol Biol Cell. 2015 Dec 1;26(24):4451-65
pubmed: 26446842
J Biol Chem. 2015 Dec 25;290(52):30670-83
pubmed: 26542804
Chem Commun (Camb). 2016 Jun 30;52(55):8612-8614
pubmed: 27327378
J Neurosci. 2016 Aug 17;36(33):8653-67
pubmed: 27535912
Methods Mol Biol. 2016;1481:1-9
pubmed: 27590146
J Alzheimers Dis. 2017;60(3):757-768
pubmed: 27662306
Angew Chem Int Ed Engl. 2017 May 22;56(22):6131-6135
pubmed: 28379629
J Lipid Res. 2018 Mar;59(3):488-506
pubmed: 29321137
J Lipid Res. 2018 Mar;59(3):515-530
pubmed: 29343537
Biol Chem. 2018 Sep 25;399(10):1157-1168
pubmed: 29908120
Chem Phys Lipids. 2018 Nov;216:114-131
pubmed: 30194926
Chem Phys Lipids. 2018 Nov;216:142-151
pubmed: 30266560
J Cell Physiol. 2019 Jun;234(6):7752-7763
pubmed: 30378111
Nat Commun. 2019 Apr 23;10(1):1832
pubmed: 31015432
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1514-1524
pubmed: 31176039
J Biol Chem. 1986 Sep 25;261(27):12610-5
pubmed: 3462189